Acción CENBF CEN BIOTECH, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas CEN Biotech, Inc.

Acciones

CENBF

CA15130L1040

Mercado cerrado - OTC Markets
Otros sitios de cotización
 17:49:14 29/04/2024 		Varia. Cinco días. Varia. 1 de enero.
0,00738 USD +138,06 % Gráfico intradía de CEN Biotech, Inc. +138,71 % +146,67 %
2023 CEN Biotech, Inc. Anuncia la dimisión de Lawrence Lehoux como miembro del Consejo y Director de Tecnología CI
2022 CEN Biotech, Inc. informa de los resultados del tercer trimestre y de los nueve meses finalizados el 30 de septiembre de 2022 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS
CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CEN BIOTECH INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS
CEN Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
CEN Biotech, Inc. announced that it has received $0.07 million in funding from 1800 Diagonal Lending, LLC
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS
CEN Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CEN BIOTECH INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
CEN Biotech, Inc. Announces Changes to Its Board
CEN BIOTECH INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
CEN Biotech, Inc. Announces Management Changes
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción CENBF
  4. Noticias CEN Biotech, Inc.
  5. Otros idiomas